Ch. du Vernay 14a
CH-Vaud
1196 格兰德
info@neumarz.com
+41.21.561.34.96
返回

Buy-and-Build: The Arbitrage Engine of Private Equity

简而言之: Buy-and-build has become the default playbook in private equity because the old shortcut, paying a low multiple and selling into a rising market, no longer works reliably. Sponsors now buy a platform company, bolt on smaller competitors at a discount, and capture the gap between what small businesses sell for and what a larger, more diversified group commands at exit. Add-on deals already represent the overwhelming majority of buyout activity in both the United States and Europe, and higher borrowing costs are pushing the strategy further because deals now need real earnings growth, not just financial engineering, to hit target returns. The approach still fails when acquisition pace outruns integration capacity. Done with discipline, it remains one of the most durable value-creation engines available, and it is the model Neumarz builds its advisory practice around.

Add-ons have quietly become the market

The buyout market that most people picture, a single sponsor buying a single company, is no longer the typical deal. In Europe, add-on transactions reached a decade-high 71.4% of buyout deal count in the first quarter of 2026, up from a 67.4% average across all of 2025, according to PitchBook. In the United States, the shift shows up from the other direction: platform buyouts, the anchor deals that create new sponsor-owned companies from scratch, fell from 21% of overall PE deal activity at the end of 2025 to roughly 19% by May 2026, with add-ons and growth equity absorbing the difference as credit tightened and valuations reset.

None of this is new so much as it is intensifying. Bain & Company has tracked buy-and-build as a distinct strategy, defined as a platform company making at least four sequential add-on acquisitions, since well before the current cycle, and found that the share of add-on deals representing at least a platform’s fourth acquisition rose from 21% in 2003 to roughly 30% in recent years, with one in ten add-ons being at least the tenth deal in a sequence. What has changed is the environment around it. Multiple arbitrage used to be one lever among several. It is now closer to the load-bearing wall.

The arithmetic behind multiple arbitrage

The mechanic is straightforward even when the execution is not. Bain’s research on the strategy shows that smaller companies consistently trade at lower valuation multiples than larger companies in the same sector, largely because scale brings more stable revenue, deeper management benches, and a wider pool of eventual buyers. A sponsor can justify paying a full, sometimes rich, multiple for a well-run platform company precisely because it plans to lower the blended purchase price over time by tucking in smaller competitors at a discount. Berlin Packaging is the case Bain returns to most often: Investcorp bought the Chicago container distributor for around $410 million in 2007, added four strategic acquisitions over seven years, and sold to Oak Hill Capital Partners in 2014 for $1.43 billion, more than three times its money. Oak Hill has since kept building on top of it.

Multiple arbitrage is not the whole return, and firms that treat it as such tend to be the ones that get burned. The stronger buy-and-build theses layer real synergies, shared back-office costs, combined purchasing power, cross-selling into the acquired base, on top of the pure valuation spread. VetCor, the veterinary practice consolidator Cressey & Company built starting in 2010, is the version that worked: add-ons priced at mid-single-digit EBITDA multiples against a platform valued in the mid-teens, in a fragmented, recession-resistant sector with genuine white space for growth.

Why higher rates make the strategy more necessary, not less

The case for buy-and-build has strengthened for a reason that has little to do with fashion. Bain’s 2026 Global Private Equity Report frames the shift as “12 is the new 5”: during the low-rate 2010s, a typical buyout needed only about 5% annual EBITDA growth to hit a standard 2.5x return over a five-year hold, because cheap debt and steadily rising multiples did most of the remaining work. With borrowing costs now in the high single digits, leverage capped well below prior norms, and entry multiples still elevated, the same target return requires something closer to 10% to 12% annual EBITDA growth.

That is a meaningfully harder number to hit through organic growth alone, particularly in mature, moderate-growth industries. Buy-and-build offers a way to manufacture EBITDA growth through acquisition rather than waiting for it to show up in same-store performance, while the multiple-arbitrage spread absorbs some of the pressure that used to come from market-wide multiple expansion. It is not a substitute for operational improvement. It is a structure that makes operational improvement compound faster.

Where the strategy breaks

The failure modes are well documented and tend to repeat. Bain’s own case history includes Aurora Foods, an early buy-and-build attempt that combined premium brands like Mrs. Butterworth’s with budget frozen-food lines under Van de Kamp’s. The acquisitions all said “food” on paper, but the businesses shared little in cost structure, customer base, or channel, and the platform filed for bankruptcy in 2003 without ever generating the promised scope. The lesson holds across sectors: an add-on has to sit close enough to the platform’s actual core, its customers, costs, channels, and competitive advantage, for the combination to be worth more than the sum of its parts.

Sector timing matters just as much as target selection. The funeral home industry is Bain’s example of a market that “barbelled”: enough consolidators piled in over the years that the mid-size targets disappeared, prices for what remained were bid up, and the multiple-arbitrage opportunity that made the strategy attractive in the first place quietly closed. A sponsor entering a sector late, without checking how much genuine acquisition runway is left, is underwriting a strategy that may already be exhausted.

What separates the platforms that compound from the ones that stall

Diligence question Signal the platform will compound Signal the platform will stall
Sector runway Fragmented market, ample smaller targets, low disruption risk Consolidators already competing for the same shrinking pool of targets
Platform readiness Strong free cash flow, systems and management able to absorb deals Platform itself needs years of fixing before it can integrate anything
Strategic fit of targets Add-ons close to the platform’s actual core customers and cost base Acquisitions justified mainly by “it’s in the same broad category”
Pace versus capacity Acquisition cadence matched to integration bandwidth Deals stacking faster than back-office and IT systems can absorb them

Building platforms, not just buying them

For Swiss and European mid-market owners, buy-and-build is rarely a strategy a company designs for itself. It is a strategy a sponsor or an outside advisor has to bring, because it requires sector-level visibility into where the fragmentation and the multiple gap actually sit, and the deal-execution discipline to keep add-ons close to the core. That is the work Neumarz does with owners and sponsors across Switzerland’s fragmented mid-market: identifying the platform candidates with real acquisition capacity, sourcing bolt-ons that genuinely extend the core rather than merely adding revenue, and pacing the integration so that growth on paper becomes growth in the numbers. In a market where multiple expansion can no longer be assumed, that discipline is not a nice-to-have. It is the return.

参考资料

  1. PitchBook, “Surge in add-ons and club deals signal investor caution in Europe,” https://pitchbook.com/news/articles/surge-in-add-ons-and-club-deals-signal-investor-caution-in-europe
  2. PitchBook, “PE pivots as platform buyouts in software fall to decade low,” https://pitchbook.com/news/articles/pe-pivots-as-platform-buyouts-in-software-fall-to-decade-low
  3. Bain & Company, “Private Equity Outlook 2026: Gaining Traction,” https://www.bain.com/insights/outlook-gaining-traction-global-private-equity-report-2026/
  4. Bain & Company, “Private Equity Buy-and-Build: How to Get It Right,” https://www.bain.com/insights/private-equity-buy-and-build-how-to-get-it-right/
Orsen Okami
奥森-奥卡米
https://www.kainjoo.com
Kainjoo 是一家品牌科技公司,为受监管行业提供符合“改善”(Kaizen)和“六西格玛”(Six Sigma)标准的品牌活动。.

Leave a Reply

您的邮箱地址不会被公开。 必填项已用 * 标注

法律声明

投资涉及高风险。

投资者在决定是否投资该提案之前,应仔细考虑向您提供的投资者协议中描述的风险和所有其他信息。

参与和投资是投机性活动,涉及高金融风险。在评估对 Neumarz(Allegory Capital & Kainjoo SA 旗下品牌)及其活动的投资时,应考虑的某些风险因素包括但不限于以下所列因素。

其中任何一项或多项风险都可能对 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的任何投资价值,以及 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的业务、财务状况或经营业绩产生重大不利影响。

投资者可能会损失其在 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的全部或部分投资。

Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 高管和董事目前不了解的其他风险和不确定因素也可能对当前活动产生不利影响。以下信息并非对 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 所面临风险的详尽总结。也无意按任何假定的优先顺序排列。与 Allegory Capital & Kainjoo SA 旗下品牌 Neumarz 的业务有关的风险主要包括

(a) 无法保证 Allegory Capital 或 Kainjoo SA 将在未来赚取利润或持续盈利;

(b) 无法保证 Allegory Capital 或 Kainjoo SA 将获得足够的资金用于未来运营或履行其在当前协议下的义务;

(c) 投资固有的风险,包括:(i) 这些资产的估值可能会大幅波动;(ii) 风险投资的监管制度不确定,新的法规或政策可能会对投资的发展产生重大不利影响;(iii) 企业的进一步发展受制于各种难以评估的因素;(iv) 公司和无形资产面临安全漏洞的风险;(v) 网络安全威胁可能造成损失或破坏;(vi) 资产市场流动性不足的风险;

(d) 投资估值困难;

(e) Allegory Capital 和 Kainjoo SA 的经营历史有限,不能保证 Allegory Capital 的投资一定会盈利;

(f) Allegory Capital 迄今尚未产生收入,因此无法保证投资回报;

(g) 董事、高级职员和关键员工可从 Allegory Capital 辞职;

(h) Allegory Capital 无法为其面临的所有风险投保;

(i) 与 Allegory Capital 业务有关的法律可能会发生变化,从而对 Allegory Capital 造成不利影响;

(j) Allegory Capital 可能会投资于没有运营历史的实体,这使得对这些实体的评估变得复 杂,并且

(k) 与外汇汇率有关的风险。

Allegory Capital 和 Kainjoo SA 目前不了解或认为不重要的其他风险和不确定因素可能会严重影响其业务、财务状况、估值、交易表现和前景。

因此,建议潜在投资者在对 Allegory Capital 或 Kainjoo SA 做出任何投资决定之前,咨询专门就此类投资提供建议的独立财务顾问。

潜在投资者应根据自身情况和可用财务资源考虑是否适合投资 Allegory Capital 或 Kainjoo SA。